Prenetics

Prenetics is a genomics-driven health sciences company headquartered in Charlotte, North Carolina. The company, publicly traded on the NASDAQ under the ticker symbol PRE, employs 122 people and generates approximately $500 million in annual revenue. Prenetics offers a range of products and services focused on prevention, early detection, and treatment of various health conditions. Their consumer DNA test, CircleDNA, utilizes whole exome sequencing to provide comprehensive genetic insights. Additionally, Insighta, a joint venture with Professor Dennis Lo, develops multi-cancer early detection technologies. Finally, ACT Genomics, Prenetics' treatment arm, specializes in comprehensive genomic profiling of solid tumors through its FDA-cleared ACTOnco platform. Driven by a commitment to innovation, Prenetics' subsidiaries work synergistically to enhance their global impact on health. The company's dedication to groundbreaking advancements in genomics underscores their mission to improve lives through scientific breakthroughs. Visit Prenetics online at prenetics.com.